Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Tumour-associated transplantation antigens of chemically induced sarcomata cross reacting with allogeneic histocompatibility antigens

Abstract

INDIVIDUAL tumour-associated transplantation antigens (TATA) of chemically induced tumours and histocompatibility antigens (HA) share the ability of inducing transplantation immunity, and have other properties in common, such as the high degree of polymorphism1–3 and a similar cell surface behaviour4. A reciprocal relationship between the quantitative expression of TATA and H-2 antigens has been observed5–6, suggesting the existence of common mechanisms either in their synthesis or in the control of their phenotypic expression. Such indirect similarity prompted us to study the existence of cross reactions between TATA and HA. We therefore determined whether 3-methylcholanthrene (MCA)-induced sarcomata possess TATA-containing allogeneic histocompatibility determinants. Here we report data from two BALB/c fibrosarcomas, ST-5 and B-2.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Basombrio, M. A., Cancer Res., 30, 2458–2462 (1970).

    CAS  PubMed  Google Scholar 

  2. Demant, P., Transplant. Rev., 15, 162–200 (1973).

    CAS  PubMed  Google Scholar 

  3. Graff, R. J., and Bailey, D. W., Transplant. Rev., 15, 26–49 (1973).

    CAS  PubMed  Google Scholar 

  4. Yefenof, E., and Klein, G., Expl Cell. Res., 88, 217–224 (1974).

    Article  CAS  Google Scholar 

  5. Haywood, G. R., and McKhann, C. F., J. exp. Med., 133, 1171–1187 (1971).

    Article  CAS  Google Scholar 

  6. Tsakraklides, E., Smith, C., Hersey, J. H., and Good, R. A., J. natn. Cancer Inst., 52, 1499–1504 (1974).

    Article  CAS  Google Scholar 

  7. Parmiani, G., Carbone, G., and Lembo, R., Cancer Res., 33, 750–754 (1973).

    CAS  PubMed  Google Scholar 

  8. Fenyo, E. M., Wiener, F., Klein, G., and Harris, H., J. natn. Cancer Inst., 51, 1865–1875 (1973).

    Article  CAS  Google Scholar 

  9. Oth, D., and Barra, Y., C.r. hebd. Séanc. Acad. Sci., Paris, 278, 177–180 (1974).

    CAS  Google Scholar 

  10. Snell, G. D., Immunogenetics, 1, 1–3 (1974).

    Article  Google Scholar 

  11. Prehn, R. T., J. natn. Cancer Inst., 45, 1039–1045 (1970).

    CAS  Google Scholar 

  12. Bodmer, W. F., Transplant. Proc., 5, 1471–1475 (1973).

    CAS  PubMed  Google Scholar 

  13. Martin, W. J., Esber, E., Cotton, W. G., and Rice, J. M., Br. J. Cancer, 28, suppl. 1, 48–61 (1973).

    Google Scholar 

  14. Colnaghi, M. I., and Della Porta, G., J. natn. Cancer Inst., 50, 173–180 (1973).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

INVERNIZZI, G., PARMIANI, G. Tumour-associated transplantation antigens of chemically induced sarcomata cross reacting with allogeneic histocompatibility antigens. Nature 254, 713–714 (1975). https://doi.org/10.1038/254713a0

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1038/254713a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing